Published in
Oxford University Press (OUP), Annals of Oncology, (29), p. viii348, 2018
DOI: 10.1093/annonc/mdy285.184
Links
Tools
The role of bevacizumab plus front-line chemotherapy in patients with malignant ascites of ovarian cancer
Journal article published in 2018 by
M. Nikolaou 
,
N. Ziras,
I. Athanasiadis,
A. Ardavanis,
M. Vaslamatzis,
N. Kentepozidis,
P. Makrantonakis,
A. N. Christopoulou,
V. Michalaki,
A. Polizos,
C. Emmanouilidis,
V. Georgoulias
,
N. Ziras,
I. Athanasiadis,
A. Ardavanis,
M. Vaslamatzis,
N. Kentepozidis,
P. Makrantonakis,
A. N. Christopoulou,
V. Michalaki,
A. Polizos,
C. Emmanouilidis,
V. Georgoulias
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 